Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
Prescription To Otc Switch FDA Advertising, Marketing & Sales

Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance

  • News

Executive Summary

Sponsors can point consumers to video displays, website information and mobile apps to help them choose products that have been switched from Rx to OTC. Draft guidance on innovative switch applications to be followed by rule-making in near future.

Table

View full table

Advertisement

Related Content

HBW Insight
Thinking About Switching? Dr Gauld On The Go-To Markets Today
Pink Sheet
Cough/Cold, Analgesic Patch Sales Ease Pain Of Private Label Growth In OTCs
HBW Insight
Cough/Cold, Analgesic Patch Sales Ease Pain Of Private Label Growth In OTCs
Pink Sheet
FDA OTC Switch Guidance Omits Some Turns As Approval Roadmap, CHPA Says
HBW Insight
FDA OTC Switch Guidance Omits Some Turns As Approval Roadmap, CHPA Says
Pink Sheet
Rulemaking For OTC Switch Process Changes Pushed To 2019
Pink Sheet
Room For Innovative Switches Could Lurk In Existing FDA Framework
Pink Sheet
FDA Encourages Novel Switch Ideas, Though NSURE Remains Unsure
Pink Sheet
FDA Aims To “NSURE” Clarity About New Paradigm For OTC Switches
Pink Sheet
FDA To Tackle Critical Generics Issue In Switch Paradigm Debate

Topics

Advertisement
Tags:
Prescription To Otc Switch FDA Advertising, Marketing & Sales
UsernamePublicRestriction

Register

PS123511

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By